Delayed graft function of cadaveric renal transplants is prevented by diltiazem.
Carmellini
M
M
Istituto di Chirurgia Generale e Sperimentale, Universitá degli Studi di Pisa, Italy.
Salvadori
M
M
Di Stefano
R
R
Bertoni
E
E
Nicita
G
G
Rosati
A
A
Taddei
G
G
Rindi
P
P
Rizzo
G
G
Mosca
F
F
D000328:Adult; D002102:Cadaver; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004110:Diltiazem / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000628:therapy; D006085:Graft Survival / Q000187:drug effects*; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000502:physiology*; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use; D012189:Retrospective Studies; D014184:Transplantation, Homologous; D017211:Treatment Failure
D002121:Calcium Channel Blockers; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D004110:Diltiazem